Research
Hormonal
GLP-1 receptor agonists reduce food intake and body weight in humans, with efficacy comparable to or rivaling bariatric surgery.
GLP-1 medications are effective for weight loss and may eventually rival bariatric surgery in efficacy. They offer a non-surgical option for treating obesity.
StrongSupportsHIGH confidence
Progressive improvements in the efficacy of GLP1RA suggest that GLP-1-based therapies may soon rival bariatric surgery as viable options for the treatment of obesity and its complications.
Why this rating
Based on multiple clinical trials and a comprehensive review.
Source
GLP-1 physiology informs the pharmacotherapy of obesity
Daniel J. Drucker · Molecular Metabolism · 2021
narrative_reviewCited 454×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →